Go back

Edward Snowden continues to be published by WikiLeaks after yet another rejection from Rolling Stone

SnowdenRollingStones

MOSCOW —  Former NSA worker and notable whistleblower, Edward Snowden, has continued to release top-secret documents about American mass-surveillance through wikileaks.org and has no plans to stop; unless of course he can get something in his favourite magazine, Rolling Stone.

According to Snowden insiders, the young fugitive on the lam has been sending all his writing including top-secrtet security leaks to Rolling Stone, but they’ve all been rejected and he’s had to go to his back-up plan.

“It’s been his life’s dream to write for Rolling Stone but he’s just not getting published there,” explained one anonymous insider close to Snowden. “He’s been settling for WikiLeaks and they’ve been pretty successful, but Rolling Stone still won’t give him the time of day.”

Although Rolling Stone has admitted that they see the value in Snowden’s writing and appreciate his passion, they say they “just don’t publish that kind of content,” and also added on his other submitted writing that “his album reviews just suck.”

Was this article helpful?
0
0

Leave a Reply

Block title

New immunotherapy treatment provides hope for aggressive cancer

By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Read Next

Block title

New immunotherapy treatment provides hope for aggressive cancer

By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Block title

New immunotherapy treatment provides hope for aggressive cancer

By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...